Asian Spectator


The Times

.

DIMERIX EXCLUSIVELY LICENSES DMX-200 IN GREATER CHINA, SOUTH KOREA AND SOUTHEAST ASIA TO EVEREST MEDICINES

  • Written by PR Newswire Asia - Asian Spectator
  • Everest Medicines licenses exclusive rights to commercialise DMX-200 for the treatment of Focal Segmental Glomerulosclerosis (FSGS) in Greater China, South Korea and Southeast Asia
  • 500,000-1 million people are estimated to be living with FSGS in the territories[1]
  • Dimerix eligible to receive upfront and potential success-based milestone payments of...

Magazine

Compressed Air Pipe and Fittings: What Every Australian Industrial Facility Needs to Know

Compressed air is the fourth utility of modern industry, right alongside electricity, gas, and water. Yet despite its critical role in powering everything from pneumatic tools to automated productio...

Common Risks Hidden in Commercial Lease Agreements

Commercial leases are often longer and more complex than tenants expect, and the fine print can carry significant financial and operational consequences over the years that follow. Many business own...

Corporate Secretarial Services in Singapore: Annual Compliance, Key Filings, and Common Mistake

Annual compliance in Singapore should not be treated as a once-a-year administrative event. It is an ongoing governance system that depends on accurate records, timely filings, disciplined approvals...

hacklink hack forum hacklink film izle hacklink z-libraryjojobetjojobetcasibomhousecleaningchantilly-va.lovable.appesim senegalbetparkbetparktelegram下载zlibrary bookscasino en ligneWPS下载superbetinsuperbetinIND RUMMYbetebetjojobetnon gamstop casinosholiganbetjojobetcasibomnon gamstop casinos uknon gamstop casinoscasinos not on gamstop